Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Skuli

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
Cancer Research|April 9, 2009
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastomaNicolas Skuli, Sylvie Monferran, Caroline Delmas, et al.
Molecular Cancer Research : MCR|June 2, 2019
Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and ProgressionAnkita Bansal, Danielle J Sanchez, Vivek Nimgaonkar, et al.
International Journal of Cancer|May 9, 2008
Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoBSylvie Monferran, Nicolas Skuli, Caroline Delmas, et al.
Cancer Research|October 22, 2010
Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alphaGuoliang Qing, Nicolas Skuli, Patrick A Mayes, et al.
Cancers|March 10, 2022
Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of GlioblastomaMorgane Le Bras, Noah Gorelick, Sylvain Pautet, et al.
Cancer Research|January 7, 2006
Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cellsNicolas Skuli, Sylvie Monferran, Caroline Delmas, et al.
Breast Cancer (Dove Medical Press)|July 27, 2017
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacyRichard E Kast, Nicolas Skuli, Samuel Cos, et al.
Animal Models and Experimental Medicine|May 7, 2026
Humanized immune system animal models and their recent applicationsNicolas Skuli, Rudra B Amin, A'ishah Bakayoko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
Preclinical evidence that SSR128129E--a novel small-molecule multi-fibroblast growth factor receptor blocker--radiosensitises human glioblastomaIsabelle Ader, Caroline Delmas, Nicolas Skuli, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
Cancer Research|April 9, 2009
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastomaNicolas Skuli, Sylvie Monferran, Caroline Delmas, et al.
Molecular Cancer Research : MCR|June 2, 2019
Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and ProgressionAnkita Bansal, Danielle J Sanchez, Vivek Nimgaonkar, et al.
International Journal of Cancer|May 9, 2008
Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoBSylvie Monferran, Nicolas Skuli, Caroline Delmas, et al.
Cancer Research|October 22, 2010
Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alphaGuoliang Qing, Nicolas Skuli, Patrick A Mayes, et al.
Cancers|March 10, 2022
Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of GlioblastomaMorgane Le Bras, Noah Gorelick, Sylvain Pautet, et al.
Cancer Research|January 7, 2006
Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cellsNicolas Skuli, Sylvie Monferran, Caroline Delmas, et al.
Breast Cancer (Dove Medical Press)|July 27, 2017
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacyRichard E Kast, Nicolas Skuli, Samuel Cos, et al.
Animal Models and Experimental Medicine|May 7, 2026
Humanized immune system animal models and their recent applicationsNicolas Skuli, Rudra B Amin, A'ishah Bakayoko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
Preclinical evidence that SSR128129E--a novel small-molecule multi-fibroblast growth factor receptor blocker--radiosensitises human glioblastomaIsabelle Ader, Caroline Delmas, Nicolas Skuli, et al.
Pageof 7